...
机译:DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01
MRC Human Genetics Unit,Institute of Genetics and Cancer, University of Edinburgh;
MRC Centre for Reproductive Health,Queen's Medical Research Institute, The University of Edinburgh;
Leap Therapeutics;
cholangiocarcinoma; Dickkopf‐1; immune tolerance; macrophage; regulatory T cell;